6.
Bouzid D, Visseaux B, Kassasseya C, Daoud A, Femy F, Hermand C
. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study. Ann Intern Med. 2022; 175(6):831-837.
PMC: 8941485.
DOI: 10.7326/M22-0308.
View
7.
Shoji K, Tsuzuki S, Akiyama T, Matsunaga N, Asai Y, Suzuki S
. Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods. J Infect Chemother. 2022; 29(1):33-38.
PMC: 9464469.
DOI: 10.1016/j.jiac.2022.09.005.
View
8.
Shoji K, Akiyama T, Tsuzuki S, Matsunaga N, Asai Y, Suzuki S
. Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan. J Infect Chemother. 2022; 28(4):591-594.
PMC: 8769918.
DOI: 10.1016/j.jiac.2022.01.009.
View
9.
Booth A, Reed A, Ponzo S, Yassaee A, Aral M, Plans D
. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PLoS One. 2021; 16(3):e0247461.
PMC: 7932512.
DOI: 10.1371/journal.pone.0247461.
View
10.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y
. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-513.
PMC: 7135076.
DOI: 10.1016/S0140-6736(20)30211-7.
View
11.
Steenkamp L, Saggers R, Bandini R, Stranges S, Choi Y, Thornton J
. Small steps, strong shield: directly measured, moderate physical activity in 65 361 adults is associated with significant protective effects from severe COVID-19 outcomes. Br J Sports Med. 2022; 56(10):568-576.
PMC: 8844956.
DOI: 10.1136/bjsports-2021-105159.
View
12.
Matsunaga N, Hayakawa K, Asai Y, Tsuzuki S, Terada M, Suzuki S
. Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide observational study. Lancet Reg Health West Pac. 2022; 22:100421.
PMC: 8923875.
DOI: 10.1016/j.lanwpc.2022.100421.
View
13.
Chen J, Bai H, Liu J, Chen G, Liao Q, Yang J
. Distinct Clinical Characteristics and Risk Factors for Mortality in Female Inpatients With Coronavirus Disease 2019 (COVID-19): A Sex-stratified, Large-scale Cohort Study in Wuhan, China. Clin Infect Dis. 2020; 71(12):3188-3195.
PMC: 7454470.
DOI: 10.1093/cid/ciaa920.
View
14.
Wang Q, Davis P, Gurney M, Xu R
. COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement. 2021; 17(8):1297-1306.
PMC: 8014535.
DOI: 10.1002/alz.12296.
View
15.
Lauring A, Tenforde M, Chappell J, Gaglani M, Ginde A, McNeal T
. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. BMJ. 2022; 376:e069761.
PMC: 8905308.
DOI: 10.1136/bmj-2021-069761.
View
16.
Kim J, Chang I, Kim Y, Min C, Yoo D, Choi H
. The Association of Pre-existing Diagnoses of Alzheimer's Disease and Parkinson's Disease and Coronavirus Disease 2019 Infection, Severity and Mortality: Results From the Korean National Health Insurance Database. Front Aging Neurosci. 2022; 14:821235.
PMC: 8934421.
DOI: 10.3389/fnagi.2022.821235.
View
17.
July J, Pranata R
. Prevalence of dementia and its impact on mortality in patients with coronavirus disease 2019: A systematic review and meta-analysis. Geriatr Gerontol Int. 2020; 21(2):172-177.
DOI: 10.1111/ggi.14107.
View
18.
Modes M, Directo M, Melgar M, Johnson L, Yang H, Chaudhary P
. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021,.... MMWR Morb Mortal Wkly Rep. 2022; 71(6):217-223.
PMC: 8830624.
DOI: 10.15585/mmwr.mm7106e2.
View
19.
Terada M, Ohtsu H, Saito S, Hayakawa K, Tsuzuki S, Asai Y
. Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan. BMJ Open. 2021; 11(6):e047007.
PMC: 8210659.
DOI: 10.1136/bmjopen-2020-047007.
View
20.
Asai Y, Nomoto H, Hayakawa K, Matsunaga N, Tsuzuki S, Terada M
. Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan. Gerontology. 2022; 68(9):1027-1037.
PMC: 8805047.
DOI: 10.1159/000521000.
View